
As part of its continuous effort to raise public awareness of balanced nutrition as part of a healthy active life in the Asia Pacific region, global nutrition company Herbalife has announced the launch of its third Asia-Pacific Wellness Tour.
The latest edition of the Tour will kick off in Hanoi, Vietnam on 3 April and would conclude on 26 April, 2015. The wellness tour would be adjoined by seven Herbalife Nutrition Advisory Board (NAB) members who will be visiting 28 cities in Australia, Cambodia, Hong Kong, India, Indonesia, Japan, Korea, Macau, Malaysia, New Zealand, Philippines, Singapore, Taiwan, Thailand and Vietnam.
Commenting on the event, William M. Rahn, Senior Vice President and Managing Director, Herbalife Asia Pacific said, "The past two Asia-Pacific Wellness Tours in 2014 were enthusiastically received, with an attendance of 43,000 across the region. As a result of these events, we have seen a marked increase in awareness on current health trends, and a heightened understanding of the importance of leading a healthy active life among consumers.”
Reportedly, the Asia-Pacific Wellness Tour returns this year with the addition of two new Herbalife NAB members- Dr Louis Ignarro, known for his exceptional contributions to cardiovascular science and Dr Chin-Kun Wang, an expert in metabolism and nutrition, has been focusing his research on human metabolism and the clinical evaluation of nutritional supplements, nutraceuticals, functional foods and herbs. Both the experts will be leading the Wellness Tour in Japan and Singapore.
Open to medical practitioners, industry partners, sports professionals and the general public, the 2015 Asia-Pacific Wellness Tour will feature a series of seminars led by the Herbalife NAB members. At each of these seminars, the NAB members will address key health and nutrition topics, including rising obesity across the region, brain health and aging, skin health and sports nutrition.
The NAB members will also provide practical tips on how selective nutritional intake can go a long way in countering the effects of a wide-range of health issues.
The company has over 7,400 employees worldwide, and its shares are traded on the New York Stock Exchange with net sales of $5 billion in 2014.